期刊文献+

E-Cadherin表达与肝细胞癌侵袭、转移的关系 被引量:1

RELATIONSHIP BETWEEN E-Cadherin AND INVASION AND METASTASIS OF HEPATOCELLULAR CARCINOMA
下载PDF
导出
摘要 目的:研究上皮性钙黏蛋白(E-Cadherin)在人肝细胞癌(hepatocellular carcinoma,HCC)中的表达情况,探讨其与肝癌侵袭转移的关系。方法:选择56例有完整随访资料的肝细胞癌及相应癌旁组织标本、20例正常肝组织标本,用RT-PCR方法检测E-Cadherin mRNA的表达。结果:①E-Cadherin在肝细胞癌组织中的表达显著低于癌旁组织和正常组织(P<0.05),而在癌旁组织和正常组织中的表达无差异(P>0.05);②E-Cadherin在肝癌组织中的表达与术后复发时间呈正相关(R2=0.887,P<0.05),与病理分级呈负相关(R2=0.823,P<0.05);③癌组织中E-Cadherin表达与肝外转移呈负相关(R2=0.839,P<0.05);④癌旁组织中E-Cadherin表达与肝外转移时间呈正相关(R2=0.861,P<0.05)。结论:E-Cadherin表达与肝细胞癌的分化程度,侵袭转移能力,复发倾向相关,通过检测E-Cadherin表达将对肝细胞癌临床转归的评估有一定指导意义。 Objective:To investigate the association between E-Cadherin expression of hepatocellular carcinoma (HCC) and its invasion and metastasis. Methods: RT-PCR analysis technology were used to detect E-Cadherin mRNA expression respectively in 56 paired HCC and non-HCC liver tissue samples and 20 normal liver tissue samples. Result:(1)The level of E-Cadherin expression in HCC was significantly lower than that in adjacent non-HCC liver tissue and in normal liver tissue ( P 〈0.05) ; but no difference was found between adjacent non-HCC liver tissue and normal liver tissue ( P 〉0.05) ; (2)E-Cadherin expression in HCC had a positive correlation with recurrence after surgical treatment (R^2 =0. 887, P 〈0.05) and an inverse correlation with pathological grade (R^2=0. 823, P 〈0.05); (3)There was an inverse correlation between E-Cadherin expression in HCC and extrahepatic metastasis (R^2 = 0. 839, P 〈0.05) ; (4) Significant positive correlations were found between E-Cadherin expression in adjacent non-HCC liver tissue and extrahepatic metastasis (R^2 =0. 861, P 〈0.05). Conclusion:E-Cadherin have an correlation with degree of tumor differentiation, capability of invasion and metastasis and tendency of recurrence, which may have some instructive significance for assessment of the outcome of HCC.
出处 《广西医科大学学报》 CAS 北大核心 2006年第5期699-702,共4页 Journal of Guangxi Medical University
基金 广西青年科技基金资助项目(No.0229029)
关键词 上皮性钙黏蛋白 肝细胞癌 侵袭转移 E-Cadherin hepatocellular carcinoma invasion and metastasis
  • 相关文献

参考文献10

  • 1Okuda K. Hepatocellular carcinoma. J Hepatol, 2000, 32(1 Suppl) :225-237. 被引量:1
  • 2Stewart BW, Kleihues P. World Cancer Report. Lyon:IARC Press for IARC/WHO, 2003. 203-207. 被引量:1
  • 3Chothia C, Jones EY. The molecular structure of cell adhesion molecules. Annu Rev Biochem, 1997, 66(7) :823-862. 被引量:1
  • 4Parkin DM, Bray F, Ferlay J,et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer, 2001,94(2) :153-156. 被引量:1
  • 5陈孝平,裘法祖,吴在德.原发性肝癌要按个体化采用以手术为主的综合治疗[J].中华外科杂志,2003,4(3):161-162. 被引量:50
  • 6Stambolic V, Mak TW, Woodgett JR. Modulation of cellular apoptotic potential: contributions to oncogenesis.Oncogene, 1999, 18(45) :6094-6103. 被引量:1
  • 7Asayama Y, Taguchi Ki K, Aishima Si S, et al. The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma., an immunohistochemical analysis of E-cadherin, alpha-catenin and betacatenin. Liver, 2002, 22(1):43-50. 被引量:1
  • 8Endo K, Ueda T, Ueyama J, et al. Immunoreactive Ecadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum Pathol, 2000, 31(5) :558-565. 被引量:1
  • 9吴衡,沈敏雄,梁玉龙,段玲玲,王丽影,徐贞,查锡良.阳性表达表皮钙粘蛋白增加G0/G1期人乳腺癌细胞比例及其分子机制[J].生物化学与生物物理进展,2003,30(3):435-441. 被引量:10
  • 10Donnellan R, Chetty R. Cyclin E in human cancers.FASEB J, 1999, 13(8):773-780. 被引量:1

二级参考文献23

  • 1Wijnhoven B P, Dinjens W N, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg, 2000, 87(8): 992-1005. 被引量:1
  • 2Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 1999, 398 (6726): 422-426. 被引量:1
  • 3Giancotti F G, Ruoslahti E. Integrin signaling. Science, 1999,285 (5430): 1028-1032. 被引量:1
  • 4Hannigan G E, Leung-Hagesteijn C, Fitz-Gibbon L, et al.Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature, 1996, 379(6560) : 91-96. 被引量:1
  • 5Wu C. ILK interactions. J Cell Sci, 2001, 114 (14): 2549-2550. 被引量:1
  • 6Tamura M, Gu J, Matsumoto K, et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science, 1998, 280 (5369): 1614-1617. 被引量:1
  • 7Shapirol G I, Harper J W. Anticancer drug targets: cell cycle and checkpoint control. J Clin Invest, 1999, 104 (12): 1645-1653. 被引量:1
  • 8Nicholson K M, Anderson N G. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal, 2002, 14(5): 381-395. 被引量:1
  • 9Cheng J Q, Godwin A K, Bellacosa A, et al. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA, 1992, 89 (19): 9267-9271. 被引量:1
  • 10Harbour J W, Luo R X, DeiSanti A, et al. CAk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1. Cell, 1999, 98 (8) :859- 869. 被引量:1

共引文献56

同被引文献8

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部